A USEFUL and effective guide for therapy of any disease requires a common understanding of the disease by the author and the reader. It is essential that the disease entity be identified before therapy is discussed, prescribed or evaluated. In many disease entities, this mutual understanding is well established by familiarity with the disease as gained by similar periods of training and experience or from information that is readily available in standard reference texts. Neither the familiarity, mutual experience, or immediate reference sources presently exist in relation to the disease under discussion. Current medical conferences conducted by participants familiar with myocardial disease are characterized by a great disparity in the concepts of the diseases of the myocardium. For these reasons, it is considered that a brief description of the author's concepts of primary myocardial disease be provided prior to a discussion of therapy.
Definition and Classification
The term primary myocardial disease as used here and in prior publications1'-refers to groups of diseases that primarily involve the myocardium and spare or only minimally involve other important structures of the heart and the cardiovascular system. By definition, it excludes secondary forms of myocardial disease complicating occlusive coronary artery disease and systemic and pulmonary hypertensive cardiovascular diseases as the disease processes in these conditions primarily involve the coronary, systemic, or pulmonary vasculature with secondary myocardial hypertrophy, degeneration, and fibrosis. Likewise, syphilis with its primary cardiovascular lesions in the aorta and aortic valve and rheumatic heart disease with its proclivity to produce valvular lesions are not ordinarily considered as primary myocardial diseases but admittedly instances occur where rheumatic lesions are primarily and only in the myocardium. Most congenital malformations produce secondary myocardial alterations of hypertrophy, dilatation, or degeneration but there are some in which the defects involve primarily the myocardium, e.g., glycogen-storage disease disease arise from faults in normal myocardial function. The appreciation of specific clinical features and hemodynamic alterations as manifestations of these faults of the myocardium as a functional unit of the cardiovascular system constitutes the basis for a positive clinical diagnosis. In spite of the great diversity of etiologic factors and a wide spectrum in its severity and clinical course as presented by primary forms of myocardial disease, it has been observed that they present clinical features that permit a positive diagnosis with an accuracy approaching that of the more common secondary forms of myocardial disease, valvular heart disease, or pericardial diseases. These clinical and hemodynamic features have been described in great detail elsewhere.1-' Familiarity with these features is essential to the correct diagnosis, and appropriate management and a careful review are recommended.
General Principles in Management
The great diversity and multiplicity of causes and variations in severity as presented by primary myocardial disease make it difficult to outline a standard procedure for therapy. Individual evaluation and management are imperative. A plan of individual evaluation and management of primary myocardial disease requires the following: (1) a sound basis for a definite or presumptive clinical diagnosis; (2) establishment of the specific cause as promptly as possible and, if not obvious, a continued search for the cause or identification of the disease mechanism involved but avoiding a change of therapy with every passing idea; (3) a careful initial bedside clinical and hemodynamic assessment of the status of myocardial function, both at rest and with activity; (4) a determination as to whether the disease is one isolated to the myocardium or to the myocardium and pericardium or whether there exists an important systemic disease of which the myocardial disease is only one element of several potential fatal or crippling features, e.g., treatment of congestive failure or heart block in diphtheritic myocarditis and ignoring the Circulation, Volume XXXI, Novemnber 1965 systemic infection and the effect of the toxin on other organs; (5) a determination of the nature of the myocardial alteration, that is, is it an acute inflammatory or destructive process or one suggesting a hypersensitivity process or, on the other hand, is it a chronic disease state with gradual impairment of myocardial function and repeated adaptive responses; (6) an assessment of the functional alterations to include arrhythmias, conduction disorders, anemias, dysproteinemias, electrolyte and enzyme abnormalities; and (7) 2. Determination of the degree of activity to be prescribed during the continuation of supportive therapy and diagnostic studies.
3. Diagnostic studies and institution of specific therapy as indicated.
4. Long-term management directed toward maximum rehabilitation consistent with the residual status of myocardial function.
5. Periodic evaluation and prevention of complications.
The presenting features which have been observed to be a threat to life are (1 ) myocardial insufficiency (congestive failure and circulatory failure), (2) from existing faults in myocardial function, a specific cause is often not obvious on initial evaluation and treatment and some remain in the idiopathic group even after autopsy study. A continued search is however maintained for a specific cause, thereby hoping to remove the patient from the idiopathic group into one of thbe other classifications, as previously listed, wherein specific therapy is available or where the disease mechanism is better understood and managed. This is a diagnostic challenge that the attending physician should accept rather than to accept the label of idiopathic disease or alcoholic myocardiopathy with; only supportive, symptomatic, and empiric therapy.
Today the physician is provided with an increasing battery of diagnostic laboratory procedures including serologic, biochemical, immunologic, and immunochemical procedures applicable to the blood and sera and biopsy technics applicable to numerous body tissues, including the myocardium,6' which offer aid in specific diagnosis.
Surgery has provided beneficial results in a few forms of primary myocardial disease, such as the removal of localized tumors of the myocardium and surgical resections of hypertrophic muscle tissue in the hypertrophic muscular lesions involving the outflow tract of the left ventricle.8 Surgical treatment in the form of the production of poudrage has been applied to infants with endomyocardial fibroelastosis9 but The nature of the long-term therapy will vary, depending upon the severity of the residual structural and functional alterations of the myocardium. Again, the most important problems are concerned with the management of myocardial insufficiency as may be manifested by (1) congestive or low-output failure; (2) arrhythmias and conduction disorders; (3) thromboembolic problems, and (4) specific therapy for the management of a systemic disease related to the primary myocardial disease.
The level of physical activity or nature of occupation permitted should be one which is tolerated without symptoms or with minimal symptoms. Graduated activity is important in the convalescent period and for successful rehabilitation. Childbearing is poorly tolerated by patients with symptomatic primary myocardial disease. The majority of so-called "'postpartum heart disease" consist of instances of idiopathic primary myocardial disease, and subsequent pregnancies are frequently disastrous.
A program of combined maintenance digitalization and judicious use of diuretics combined with restriction of sodium intake and physical activity provide thbe best form of therapy for those with continued features of congestion or with recurring episodes of congestive failure. Periodic therapy with vigorous diuresis should be avoided as complications of hemoconcentration, dehydration, and electrolyte imbalances result in serious and often fatal complications. Fatigue, exertional dizziness, and syncope occurring from low-output failure are best managed by limitation of activity and avoidance of sudden bouts of exertion.
Troublesome arrhythmias are managed by conventional therapy. Special attention should be given to unstable rhythms associated with atrioventricular block, as such may suddenly occur in chronic primary myocardial disease. Hospitalization and therapy are indicated as previously described. The implantation of a pacemaker deserves serious consideration in long-term management of those with complete heart block.
Anticoagulant therapy is an important part of long-term management, especially in those with persistent cardiac dilatation, low-output failure, or previous embolic episodes.
When primary myocardial disease occurs as a manifestation of systemic disease and when the disease itself cannot be cured, maintenance or supportive therapy becomes important. Steroid therapy for management of sarcoid, trichinosis, hypersensitivity states and collagen diseases may be beneficial. Thyroid medication becomes an important part of the management of the myocardial faults in severe hypothyroidism. Appropriate treatment of dysproteinemias, anemias, and chronic electrolyte abnormalities is important in the management of forms of primary myocardial disease associated with chronic nutritional and metabolic disorders. The causal relationship of alcohol intake and poor nutritional intake to the so-called alcoholic cardiomyopathy is yet to be clearly established. However, the highly suggestive relationship of excessive alcohol intake to some of the chronic forms of the disease is sufficient to warrant abstinence from alcohol and for the establishment of a well-balanced diet in these instances in which the two conditions coexist.
Lastly, the prevention of infections, especially of the respiratory and urinary tracts, is Circulation, Volume XXXII, November 1965 most important in these patients, as they constitute circulatory stresses that often precipitate or seriously aggravate existing congestive failure or arrhythmias in a patient otherwise doing well.
Prognosis and Prevention
The prognosis of primary myocardial disease has steadily improved in recent years as more has been learned as to cause, pathogenesis, and the nature of hemodynamic abnormalities. Earlier broad definition as used herein. The recognition of the clinical features of the disease provide the basis for an early and accurate diagnosis and differentiation from other forms of cardiovascular diseases. Knowledge of the various types of primary myocardial disease as given in the classification provided here permits a prompt diagnosis and the application of appropriate therapy as well as an intelligent basis for the search of the cause and therapy for those initially classified as idiopathic or simply as myocardial diseases of unknown cause.
